Interestingly, the overexpression of PD-L1 does correlate and is involved in supporting cancer progression by promoting epithelial-to-mesenchymal-transition (EMT) program, together with stemness and tumor cell invasiveness through PI3K-AKT and MAPK pathways [5]. The gene discussed is AKT1; the disease is neoplasm.